Diamond Shruumz Edibles Recall Linked to 113 Illnesses and 2 Possible Deaths

Saturday, 10 August 2024, 09:49

The FDA has released preliminary lab results regarding the recalled microdosing edibles manufactured by Diamond Shruumz. The investigation reveals that these products are associated with at least 113 reported illnesses, with concerns mounting over two deaths that may be linked to their consumption. Consumers are advised to avoid these products as further testing continues. The situation underscores the need for stringent safety measures in the edible cannabis industry.
Wkrn
Diamond Shruumz Edibles Recall Linked to 113 Illnesses and 2 Possible Deaths

Diamond Shruumz Edibles Recall Overview

On Thursday, the Federal Drug Administration (FDA) published initial laboratory findings in connection to the recall of Diamond Shruumz's microdosing edibles.

Illnesses and Potential Fatalities

These recalled edibles are now implicated in 113 reported illnesses, and authorities are investigating the possibility of 2 linked deaths.

Consumer Advisory

  • Consumers are strongly urged to refrain from consuming these products.
  • Further testing is ongoing to ascertain the reasons behind the illnesses.
  • This incident highlights the critical need for enhanced safety protocols in the edible cannabis sector.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe